Als Biopharma LLC - 18902 Doylestown, PA

Business Name: Als Biopharma LLC
Categorized In: Research and Development Laboratories
Address: 3805 Old Easton Road, Doylestown, PA 18902
Phone Number: (215) 489-4944
Contact Person: Kathleen Czupich, Marketing
Website Address: alsbiopharma.com
NAICS Code: 9999900
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2009
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): Unknown
Share This Business:
Similar Businesses: Gfree Bio LLC - Doylestown, PA 18902
Shar-X Biopharma LLC - Doylestown, PA 18902
Fox Chase Chem Diversity Center - Doylestown, PA 18902
Clinical Mobilty Technology - Doylestown, PA 18902
Alliance Discovery Inc - Doylestown, PA 18902
Serome Biosciences - Doylestown, PA 18902
Zasloff Laboratories - Doylestown, PA 18902
Toph Biologicals Inc - Doylestown, PA 18902
Alis Life Science LLC - Doylestown, PA 18902
Captivate Pharmaceuticals - Doylestown, PA 18902
Jiffy Lid Technologies LLC - Doylestown, PA 18902
Pennsylvania Drug Discovery Institute - Doylestown, PA 18902
Cherry Pharmaceutical - Doylestown, PA 18902
Jbs Science Inc - Doylestown, PA 18902
Pharmabridge Inc - Doylestown, PA 18902
Immunotope Diagnostics Inc - Doylestown, PA 18902
Enantigen Therapeutics Inc - Doylestown, PA 18902

Als Biopharma LLC provides professional Research and Development Laboratories from its single location at the coordinates 40.33258,-75.12647.

The company offers B2B variables under the SIC code 8731 and NAICS code 9999900, while making an annual revenue of Unknown and hiring a total of 1 to 4 employees.

Founded in 2009, the company can now be visited at 3805 Old Easton Road, Doylestown, Pennsylvania 18902 or contacted through representative Kathleen Czupich, Marketing at (215) 489-4944.

For frequently asked questions and further inquiries about professional Research and Development Laboratories, get to know more about Als Biopharma LLC through its company website at alsbiopharma.com. Engage with this business on its social media platforms through on Twitter and on Facebook.